:: Volume 30, Issue 3 (7-2018) ::
J Iran Dent Assoc 2018, 30(3): 126-131 Back to browse issues page
A New Approach for Treatment and Prevention of Recurrent Oral Lichen Planus: A Technical Report
Farzaneh Agha-Hosseini1 , Mahdieh-Sadat Moosavi2 , Reyhaneh Varshochian3 , Khatereh Akbari * 4
1- Professor, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran, AND Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
2- Associate Professor, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran, AND Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
3- PhD, Nanotechnology Research Centre, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4- Oral and Maxillofacial Medicine Specialist, Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sci-ences, Tehran, Iran , kh_akbari@yahoo.com
Abstract:   (2934 Views)
Introduction: Oral lichen planus (OLP) is an autoimmune disease with uncertain etiopathogenecity and no definitive treatment. Considering the recurrent nature of OLP, finding an adjunctive treatment to minimize the risk of chronicity and recurrence of OLP and to decrease the adverse effects of corticosteroids can be promising. This study aimed to assess the efficacy of a mixture of hyaluronic acid and triamcinolone in the treatment of OLP.
Case Presentation: This study involved five OLP patients. In each patient, the mixture of hyaluronic acid/triamcinolone was injected intralesionally into the case lesion, while triamcinolone alone was injected into the control lesion. The patients were followed-up at 14 and 28 days post-intervention and then monthly for 9 months. Recurrences were observed in three control lesions, while the patients did not show any aggravation or recurrence in the case lesions. Conclusion: It appears that triamcinolone/hyaluronic acid mixture is potentially beneficial in the treatment of OLP.
Keywords: Oral Lichen Planus, Hyaluronic Acid, Triamcinolone
Full-Text [PDF 335 kb]   (1234 Downloads)    
Type of Study: Case Series | Subject: Oral Medicine
References
1. Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S, Karagah A. Efficacy of purslane in the treatment of oral lichen planus. Phytother Res. 2010 Feb;24(2):240-4.
2. Eisen D. The clinical features, malignant potential, and systemic associations of oral li-chen planus: a study of 723 patients. J Am Acad Dermatol. 2002 Feb;46(2):207-14.
3. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001 Oct;33(4):289-94.
4. Stanbury RM, Graham EM. Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol. 1998 Jun;82(6): 704-8.
5. Chang CY, Chan AT, Armstrong PA, Luo HC, Higuchi T, Strehin IA, et al. Hyaluronic acid-human blood hydrogels for stem cell transplantation. Biomaterials. 2012 Nov;33(32): 8026-33.
6. Han L, Zhao Y, Yin L, Li R, Liang Y, Huang H, et al. Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular deliv-ery. AAPS PharmSciTech. 2012 Sep;13(3):836-45.
7. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule de-livery in regenerative medicine. J Control Re-lease. 2011 Oct 30;155(2):193-9.
8. van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently avail-able diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003 Oct; 32 (9):507-12.
9. Agha-Hosseini F, Mirzaii-Dizgah I, Mohammadpour N. Muscarinic cholinergic receptors (MR3) in saliva of patients with oral lichen planus. Arch Dermatol Res. 2016 Sep; 308 (7):481-6.
10. Thongprasom K, Dhanuthai K. Steriods in the treatment of lichen planus: a review. J Oral Sci. 2008 Dec;50(4):377-85.
11. Xiong C, Li Q, Lin M, Li X, Meng W, Wu Y, et al. The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med. 2009 Aug;38(7):551-8.
12. Agha-Hosseini F, Moslemi E, Mirzaii-Dizgah I. Comparative evaluation of low-level laser and CO2 laser in treatment of patients with oral li-chen planus. Int J Oral Maxillofac Surg. 2012 Oct; 41 (10):1265-9.
13. Jokar A, Davari T, Asadi N, Ahmadi F, Foruhari S. Comparison of the Hyaluronic Acid Vaginal Cream and Conjugated Estrogen Used in Treatment of Vaginal Atrophy of Menopause Women: A Randomized Controlled Clinical Tri-al. Int J Community Based Nurs Midwifery. 2016 Jan; 4(1):69-78.
14. Nolan A, Badminton J, Maguire J, Seymour RA. The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med. 2009 Mar;38(3):299-303.
15. Shetty RR, Burde KN, Guttal KS. The Efficacy of Topical Hyaluronic Acid 0.2% in the Management of Symptomatic Oral Lichen Planus. J Clin Diagn Res. 2016 Jan;10(1):ZC46-50.
16. Penning LI, de Bie RA, Walenkamp GH. Subacromial triamcinolone acetonide, hyaluron-ic acid and saline injections for shoulder pain an RCT investigating the effectiveness in the first days. BMC Musculoskelet Disord. 2014 Oct 23;15:352.

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 30, Issue 3 (7-2018) Back to browse issues page